CEACAM5 and systemic mastocytosis: An elevated CEA serum level was observed in 55% to 83.9% of the patients at the time of SM diagnosis, while the imaging diagnosis included CT scan in 87.1% of the patients and PET-CT in 12.9% of the patients.